Ferric Oxyhydroxide Patent Expiration
Ferric Oxyhydroxide was first introduced by Sanofi Aventis Us Llc
Ferric Oxyhydroxide Patents
Given below is the list of patents protecting Ferric Oxyhydroxide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Velphoro |
US10624855 (Pediatric) | Pharmaceutical composition, comprising phosphate binder particles | May 26, 2035 | Vifor Fresenius |
| Velphoro |
US11234938 (Pediatric) | Pharmaceutical composition, comprising phosphate binder particles | May 26, 2035 | Vifor Fresenius |
| Velphoro |
US11446252 (Pediatric) | Pharmaceutical composition, comprising phosphate binder particles | May 26, 2035 | Vifor Fresenius |
| Velphoro | US10624855 | Pharmaceutical composition, comprising phosphate binder particles | Nov 26, 2034 | Vifor Fresenius |
| Velphoro | US11234938 | Pharmaceutical composition, comprising phosphate binder particles | Nov 26, 2034 | Vifor Fresenius |
| Velphoro | US11446252 | Pharmaceutical composition, comprising phosphate binder particles | Nov 26, 2034 | Vifor Fresenius |
| Velphoro |
US9561251 (Pediatric) | Pharmaceutical compositions | Jul 23, 2030 | Vifor Fresenius |
| Velphoro | US9561251 | Pharmaceutical compositions | Jan 23, 2030 | Vifor Fresenius |
| Velphoro |
US10682376 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10695367 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10925896 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10925897 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10933090 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US11013761 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US11013762 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro | US10682376 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10695367 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10925896 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10925897 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10933090 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US11013761 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US11013762 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US6174442 | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent |
Jun 12, 2020
(Expired) | Vifor Fresenius |
| Dexferrum | US5624668 | Iron dextran formulations |
Sep 29, 2015
(Expired) | Am Regent |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Ferric Oxyhydroxide's patents.
Latest Legal Activities on Ferric Oxyhydroxide's Patents
Given below is the list recent legal activities going on the following patents of Ferric Oxyhydroxide.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10695367 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10682376 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Oct, 2023 | US10624855 |
| Patent Issue Date Used in PTA Calculation Critical
| 20 Sep, 2022 | US11446252 |
| Recordation of Patent Grant Mailed Critical
| 20 Sep, 2022 | US11446252 |
| Email Notification Critical
| 01 Sep, 2022 | US11446252 |
| Issue Notification Mailed Critical
| 31 Aug, 2022 | US11446252 |
| Application Is Considered Ready for Issue Critical
| 23 Aug, 2022 | US11446252 |
| Dispatch to FDC | 23 Aug, 2022 | US11446252 |
| Issue Fee Payment Received Critical
| 12 Aug, 2022 | US11446252 |
Ferric Oxyhydroxide's Family Patents
